SM_165a: Pulmonary Hypertension Flashcards

1
Q

Group 1 pulmonary hypertension is _______

A

Group 1 pulmonary hypertension is pulmonary arterial hypertension

(associated with connective tissue disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Group 2 pulmonary hypertension is _______

A

Group 2 pulmonary hypertension is pulmonary hypertension owing to left heart disease

(left sided pressures high so right sided pressures high)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Group 3 pulmonary hypertension is _______

A

Group 3 pulmonary hypertension is pulmonary hypertension owing to lung disease or hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Group 4 pulmonary hypertension is _______

A

Group 4 pulmonary hypertension is chronic thromboembolic pulmonary hypertension

(abnormal V/Q scan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Group 5 pulmonary hypertension is _______

A

Group 5 pulmonary hypertension is pulmonary hypertension with unclear multifactorial mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Normal CVP is _____ mmHg

A

Normal CVP is <8 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normal RAP is _____ mmHg

A

Normal RAP is 2-8 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Normal RV pressure is _____ mmHg

A

Normal RV pressure is 20-30 mmHg systolic and less than RAP diastolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Normal PA pressure is ______

A

Normal PA pressure is 20-25 / 5-15 mmHg

(mean = 14 mmHg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Normal PCWP is _____ mmHg

A

Normal PCWP is 6-12 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normal LV pressure is ____ mmHg

A

Normal LV pressure is 120 / 6-12 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Normal LAP is ____ mmHg

A

Normal LAP is 6-10 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class 1: PAH

  • mPAP at rest:
  • PCWP:
  • PVR:
A

Class 1: PAH

  • mPAP at rest: ≥ 25 mmHg
  • PCWP: ≤ 15 mmHg
  • PVR: > 3 Wood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Class 2: PVH

  • mPAP at rest:
  • PCWP:
A

Class 2: PVH

  • mPAP at rest: ≥ 25 mmHg
  • PCWP: ≥ 15 mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class 3: PH associated with lung disease

  • mPAP at rest:
A

Class 3: PH associated with lung disease

  • mPAP at rest: > 25 mmHg
  • Underlying chronic lung disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class 4: PH CTEPH

  • mPAP at rest:
  • PCWP:
A

Class 4: PH CTEPH

  • mPAP at rest: > 25 mmHg
  • PCWP: ≤ 15 mmHg
  • Evidence of chronic perfusion defects
17
Q

Class 1: PAH

Pathology

A

Class 1: PAH

Pathology

  • Smooth muscle hypertrophy
  • Neointima formation (neo-vascularization)
  • Endothelial cell proliferation (monoclonality)
    *
18
Q

Class 2: PVH

Pathology

  • *
A

Class 2: PVH

Pathology

  • Medial thickening
  • Occlusive venopathy
19
Q

Class 3: PH associated with lung disease

Pathology

  • *
A

Class 3: PH associated with lung disease

Pathology

  • Factor VIII staining
  • Smooth muscle hypertrophy
20
Q

Class 4: PH CTEPH

Ventilation ___ perfusion

A

Class 4: PH CTEPH

Ventilation > perfusion

21
Q

Where is the lesion in each type of PH?

A
  • Group 1: pulmonary arteries (smaller)
  • Group 2: pulmonary veins
  • Group 3: capillaries (parenchymal lung disease)
  • Group 4: arteries in lungs (larger)
22
Q

Echocardiographic changes in Group 1 pulmonary hypertension are _____ sided

A

Echocardiographic changes in Group 1 pulmonary hypertension are right sided

(enlargement of RA and RV, poorly functioning RV)

Group 1 is PAH

23
Q

Echocardiographic changes in Group 2 pulmonary hypertension are _____ sided

A

Echocardiographic changes in Group 2 pulmonary hypertension are left sided

(reduced LV EF and dilated LA)

Group 2 is PVH

24
Q

Compare and contrast features of PAH and PVH

25
Normal V/Q scan makes CTEPH \_\_\_\_\_\_
Normal V/Q scan makes CTEPH unlikely (CT scan may underestimate the degree of obstruction in CTEPH)
26
The gold standard in the diagnostic work up of pulmonary hypertension is \_\_\_\_\_
The gold standard in the diagnostic work up of pulmonary hypertension is right heart catheterization * direct measurement of RAP, PAP, PCWP, CO * calculation of PVR and CI * detetermination of intracardiac shunt * determination of acute vasodilator activity
27
Why is characterizing the type of pulmonary hypertension important?
* Therapies differ drastically between groups * Incorrect treatment can worsen a patient's clinical status * PAH treatments are costly
28
PVH is _____ common, while PAH is _____ common
PVH is very common, while PAH is not common
29
Presenting symptoms of PAH are often \_\_\_\_\_
Presenting symptoms of PAH are often non-specific
30
Group 1 pulmonary hypertension (PAH) is treated with \_\_\_\_\_\_\_
Group 1 pulmonary hypertension (PAH\_ is treated with pulmonary vasodilator therapy (dilates pre-capillary bed, meaning the small pulmonary arteries)
31
Treatment of Group 1 pulmonary hypertension (PAH) centers on three pathways: \_\_\_\_\_\_, \_\_\_\_\_\_, and \_\_\_\_\_\_
Treatment of Group 1 pulmonary hypertension (PAH) centers on three pathways: endothelin pathway, nitric oxide pathway, prostacyclin * Endothelin promotes vasoconstriction - downregulated in treatment * Nitric oxide promotes vasodilation - upregulated in treatment * Prostacyclin promotes vasodilation - upregulated in treatment
32
Group 2 pulmonary hypertension (PVH) is treated by ______ and with \_\_\_\_\_\_\_
Group 2 pulmonary hypertension (PVH) is treated by optimizing heart failure medications and with diuresis (PDE-5 may be useful)
33
Pulmonary vasodilators are not used in treatment of Group 2 pulmonary hypertension (PVH) because of \_\_\_\_\_\_
Pulmonary vasodilators are not used in treatment of Group 2 pulmonary hypertension (PVH) because of theoretical risk of pulmonary edema
34
Group 3 pulmonary hypertension (PH lung disease) is treated by ______ and \_\_\_\_\_\_\_
Group 3 pulmonary hypertension (PH lung disease) is treated by optimizing lung disease medications and reversing hypoxia (PDE-5 may be useful)
35
Pulmonary vasodilators are not used in treatment of Group 3 pulmonary hypertension (PH lung disease) because of \_\_\_\_\_\_
Pulmonary vasodilators are not used in treatment of Group 3 pulmonary hypertension (PH lung disease) because of theoretical risk of increasing V/Q mismatching and worsening hypoxemia (no clear benefit from PAH specific therapy and trend toward increased oxygen requirement for Group 3 patients)
36
Group 4 hypertension (CTEPH) is treated with \_\_\_\_\_\_, \_\_\_\_\_\_, and \_\_\_\_\_\_
Group 4 hypertension (CTEPH) is treated with anticoagulation, pulmonary vasodilators in non-operative candidates, and thromboendarterectomy
37
Group 2 pulmonary hypertension (PVH) and Group 3 pulmonary hypertension (PH lung disease) would be sometimes referred to as \_\_\_\_\_\_\_
Group 2 pulmonary hypertension (PVH) and Group 3 pulmonary hypertension (PH lung disease) would be sometimes referred to as "out of proportion"
38
What is lung disease with severe PH?
* Minority of chronic lung disease patients suspected to have severe vascular abnormalities * Circulatory impairment is primary driver of reduced exercise capacity rather than ventilatory impairment related to lung disease